Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia. 2008

Boris B Quednow, and Ingo Frommann, and Julia Berning, and Kai-Uwe Kühn, and Wolfgang Maier, and Michael Wagner
Department of Psychiatry, University of Bonn, Bonn, Germany. quednow@bli.uzh.ch

BACKGROUND Schizophrenia patients exhibit impairment in prepulse inhibition (PPI) of the acoustic startle response (ASR), which is commonly interpreted as a sensorimotor gating deficit. To date, it is unclear when these gating deficits arise. Results of animal studies and some human data suggest that PPI deficits are in part genetically determined, such that gating deficits could be present before the onset of a full-blown psychosis. To test this assumption, we investigated PPI of ASR in individuals with prodromal symptoms of schizophrenia and patients with first-episode schizophrenia. METHODS Startle reactivity, habituation, and PPI of ASR, as well as a neuropsychological test battery, were assessed in 54 subjects with prodromal symptoms of schizophrenia (35 early and 19 late prodromal subjects), 31 first-episode schizophrenia patients (14 unmedicated, 17 medicated), and 28 healthy control subjects. Patients were also examined with the Positive and Negative Syndrome Scale and the Global Assessment of Functioning Scale. RESULTS Prodromal subjects and unmedicated patients with first-episode schizophrenia showed significant PPI deficits, whereas schizophrenia patients treated with risperidone had almost normal PPI. Startle reactivity decreased with greater severity of symptoms (control subjects, early prodromal group > late prodromal group > unmedicated first-episode patients) but was almost normal in the medicated patients. With respect to habituation, prodromal subjects and schizophrenia patients did not differ from healthy control subjects. CONCLUSIONS PPI disruption is already present in a prodromal state of schizophrenia, but startle reactivity deficits seem to emerge with the onset of acute psychosis.

UI MeSH Term Description Entries
D007266 Inhibition, Psychological The interference with or prevention of a behavioral or verbal response even though the stimulus for that response is present; in psychoanalysis the unconscious restraining of an instinctual process. Inhibition (Psychology),Inhibition, Psychology,Psychological Inhibition,Inhibitions (Psychology),Inhibitions, Psychological,Inhibitions, Psychology,Psychological Inhibitions,Psychology Inhibition,Psychology Inhibitions
D008297 Male Males
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D005260 Female Females
D006185 Habituation, Psychophysiologic The disappearance of responsiveness to a repeated stimulation. It does not include drug habituation. Habituation (Psychophysiology),Habituation, Psychophysiological,Psychophysiologic Habituation,Psychophysiological Habituation,Habituations (Psychophysiology)
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000161 Acoustic Stimulation Use of sound to elicit a response in the nervous system. Auditory Stimulation,Stimulation, Acoustic,Stimulation, Auditory
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Boris B Quednow, and Ingo Frommann, and Julia Berning, and Kai-Uwe Kühn, and Wolfgang Maier, and Michael Wagner
September 1990, Brain research bulletin,
Boris B Quednow, and Ingo Frommann, and Julia Berning, and Kai-Uwe Kühn, and Wolfgang Maier, and Michael Wagner
February 1997, Neuroscience,
Boris B Quednow, and Ingo Frommann, and Julia Berning, and Kai-Uwe Kühn, and Wolfgang Maier, and Michael Wagner
June 2010, Neuropeptides,
Boris B Quednow, and Ingo Frommann, and Julia Berning, and Kai-Uwe Kühn, and Wolfgang Maier, and Michael Wagner
April 2000, Biological psychiatry,
Boris B Quednow, and Ingo Frommann, and Julia Berning, and Kai-Uwe Kühn, and Wolfgang Maier, and Michael Wagner
January 1987, Schizophrenia bulletin,
Boris B Quednow, and Ingo Frommann, and Julia Berning, and Kai-Uwe Kühn, and Wolfgang Maier, and Michael Wagner
January 1993, Psychopharmacology,
Boris B Quednow, and Ingo Frommann, and Julia Berning, and Kai-Uwe Kühn, and Wolfgang Maier, and Michael Wagner
March 2008, Journal of neurophysiology,
Boris B Quednow, and Ingo Frommann, and Julia Berning, and Kai-Uwe Kühn, and Wolfgang Maier, and Michael Wagner
November 1994, The Journal of pharmacology and experimental therapeutics,
Boris B Quednow, and Ingo Frommann, and Julia Berning, and Kai-Uwe Kühn, and Wolfgang Maier, and Michael Wagner
April 1994, Brain research,
Boris B Quednow, and Ingo Frommann, and Julia Berning, and Kai-Uwe Kühn, and Wolfgang Maier, and Michael Wagner
November 2008, Neuroscience research,
Copied contents to your clipboard!